Selected research
Industry Research
Quetiapine Fumarate Tablets Industry Research Report 2026
Market perspective
The global Quetiapine Fumarate Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Quetiapine Fumarate Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Quetiapine Fumarate Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Quetiapine Fumarate Tablets include Teva Pharmaceuticals, Sun Pharma, Sandoz, Lupin Limited, Hunan Dongting Pharmaceutical, Hikma, Dr. Reddy's Laboratories, AstraZeneca and Alkem Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Quetiapine Fumarate Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Quetiapine Fumarate Tablets Market by Company
Teva Pharmaceuticals
Sun Pharma
Sandoz
Lupin Limited
Hunan Dongting Pharmaceutical
Hikma
Dr. Reddy's Laboratories
AstraZeneca
Alkem Laboratories
Quetiapine Fumarate Tablets Segment by Type
0.2g
0.3g
Others
Quetiapine Fumarate Tablets Segment by Application
Hospital
Clinic
Others
Quetiapine Fumarate Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine Fumarate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Quetiapine Fumarate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine Fumarate Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Quetiapine Fumarate Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Quetiapine Fumarate Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Quetiapine Fumarate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.2g
- 0.3g
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Teva Pharmaceuticals
- Sun Pharma
- Sandoz
- Lupin Limited
- Hunan Dongting Pharmaceutical
- Hikma
- Dr. Reddy's Laboratories
- AstraZeneca
- Alkem Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Quetiapine Fumarate Tablets Market Size (2021-2032)
- 2.2.2 Global Quetiapine Fumarate Tablets Sales (2021-2032)
- 2.2.3 Global Quetiapine Fumarate Tablets Market Average Price (2021-2032)
- 2.3 Quetiapine Fumarate Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.2g
- 2.3.3 0.3g
- 2.3.4 Others
- 2.4 Quetiapine Fumarate Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Quetiapine Fumarate Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Quetiapine Fumarate Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Quetiapine Fumarate Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Quetiapine Fumarate Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Quetiapine Fumarate Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Quetiapine Fumarate Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Quetiapine Fumarate Tablets, Product Type & Application
- 3.8 Global Manufacturers of Quetiapine Fumarate Tablets, Established Date
- 3.9 Global Quetiapine Fumarate Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceuticals
- 4.1.1 Teva Pharmaceuticals Company Information
- 4.1.2 Teva Pharmaceuticals Business Overview
- 4.1.3 Teva Pharmaceuticals Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceuticals Quetiapine Fumarate Tablets Product Portfolio
- 4.1.5 Teva Pharmaceuticals Recent Developments
- 4.2 Sun Pharma
- 4.2.1 Sun Pharma Company Information
- 4.2.2 Sun Pharma Business Overview
- 4.2.3 Sun Pharma Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharma Quetiapine Fumarate Tablets Product Portfolio
- 4.2.5 Sun Pharma Recent Developments
- 4.3 Sandoz
- 4.3.1 Sandoz Company Information
- 4.3.2 Sandoz Business Overview
- 4.3.3 Sandoz Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sandoz Quetiapine Fumarate Tablets Product Portfolio
- 4.3.5 Sandoz Recent Developments
- 4.4 Lupin Limited
- 4.4.1 Lupin Limited Company Information
- 4.4.2 Lupin Limited Business Overview
- 4.4.3 Lupin Limited Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lupin Limited Quetiapine Fumarate Tablets Product Portfolio
- 4.4.5 Lupin Limited Recent Developments
- 4.5 Hunan Dongting Pharmaceutical
- 4.5.1 Hunan Dongting Pharmaceutical Company Information
- 4.5.2 Hunan Dongting Pharmaceutical Business Overview
- 4.5.3 Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Product Portfolio
- 4.5.5 Hunan Dongting Pharmaceutical Recent Developments
- 4.6 Hikma
- 4.6.1 Hikma Company Information
- 4.6.2 Hikma Business Overview
- 4.6.3 Hikma Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hikma Quetiapine Fumarate Tablets Product Portfolio
- 4.6.5 Hikma Recent Developments
- 4.7 Dr. Reddy's Laboratories
- 4.7.1 Dr. Reddy's Laboratories Company Information
- 4.7.2 Dr. Reddy's Laboratories Business Overview
- 4.7.3 Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Product Portfolio
- 4.7.5 Dr. Reddy's Laboratories Recent Developments
- 4.8 AstraZeneca
- 4.8.1 AstraZeneca Company Information
- 4.8.2 AstraZeneca Business Overview
- 4.8.3 AstraZeneca Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 AstraZeneca Quetiapine Fumarate Tablets Product Portfolio
- 4.8.5 AstraZeneca Recent Developments
- 4.9 Alkem Laboratories
- 4.9.1 Alkem Laboratories Company Information
- 4.9.2 Alkem Laboratories Business Overview
- 4.9.3 Alkem Laboratories Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Alkem Laboratories Quetiapine Fumarate Tablets Product Portfolio
- 4.9.5 Alkem Laboratories Recent Developments
5 Global Quetiapine Fumarate Tablets Market Scenario by Region
- 5.1 Global Quetiapine Fumarate Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Quetiapine Fumarate Tablets Sales by Region: 2021-2032
- 5.2.1 Global Quetiapine Fumarate Tablets Sales by Region: 2021-2026
- 5.2.2 Global Quetiapine Fumarate Tablets Sales by Region: 2027-2032
- 5.3 Global Quetiapine Fumarate Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Quetiapine Fumarate Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Quetiapine Fumarate Tablets Revenue by Region: 2027-2032
- 5.4 North America Quetiapine Fumarate Tablets Market Facts & Figures by Country
- 5.4.1 North America Quetiapine Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Quetiapine Fumarate Tablets Sales by Country (2021-2032)
- 5.4.3 North America Quetiapine Fumarate Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Quetiapine Fumarate Tablets Market Facts & Figures by Country
- 5.5.1 Europe Quetiapine Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Quetiapine Fumarate Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Quetiapine Fumarate Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Quetiapine Fumarate Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Quetiapine Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Quetiapine Fumarate Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Quetiapine Fumarate Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Quetiapine Fumarate Tablets Market Facts & Figures by Country
- 5.7.1 South America Quetiapine Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Quetiapine Fumarate Tablets Sales by Country (2021-2032)
- 5.7.3 South America Quetiapine Fumarate Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Quetiapine Fumarate Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Quetiapine Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Quetiapine Fumarate Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Quetiapine Fumarate Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Quetiapine Fumarate Tablets Sales by Type (2021-2032)
- 6.1.1 Global Quetiapine Fumarate Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Quetiapine Fumarate Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Quetiapine Fumarate Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Quetiapine Fumarate Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Quetiapine Fumarate Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Quetiapine Fumarate Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Quetiapine Fumarate Tablets Sales by Application (2021-2032)
- 7.1.1 Global Quetiapine Fumarate Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Quetiapine Fumarate Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Quetiapine Fumarate Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Quetiapine Fumarate Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Quetiapine Fumarate Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Quetiapine Fumarate Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Quetiapine Fumarate Tablets Value Chain Analysis
- 8.1.1 Quetiapine Fumarate Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Quetiapine Fumarate Tablets Production Mode & Process
- 8.2 Quetiapine Fumarate Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Quetiapine Fumarate Tablets Distributors
- 8.2.3 Quetiapine Fumarate Tablets Customers
9 Global Quetiapine Fumarate Tablets Analyzing Market Dynamics
- 9.1 Quetiapine Fumarate Tablets Industry Trends
- 9.2 Quetiapine Fumarate Tablets Industry Drivers
- 9.3 Quetiapine Fumarate Tablets Industry Opportunities and Challenges
- 9.4 Quetiapine Fumarate Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst